Ferraz MB. When should the physician question information disseminated by the pharmaceutical industry?. Sao Paulo Med J [Internet]. 1997 Jul. 7 [cited 2025 Jun. 1];115(4):1467-8. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2111